Adenovirus Infections (DBCOND0051512)

Identifiers

Synonyms

Adenovirus Infection / Adenoviral infections / Adenovirus infection, unspecified / Disease due to Adenovirus (disorder) / Adenovirus infection NOS / Adenoviridae Infections

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT01070797	Administration of Rapidly Generated Multivirus-specific Cytotoxic T-Lymphocytes (VIRAGE)	No drug interventions	treatment	1	completed
NCT00590083	Administration of Virus-Specific Cytotoxic T-Lymphocytes	No drug interventions	treatment	1	completed
NCT02007356	A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture System®	No drug interventions	treatment	2	recruiting
NCT05101213	Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients	No drug interventions	treatment	1	recruiting
NCT05179057	Posoleucel (ALVR105) for the Treatment of Adenovirus Infection in Pediatric and Adult Participants Receiving Standard of Care Following Allogeneic Hematopoietic Cell Transplantation	Posoleucel	treatment	3	terminated
NCT02276820	Most Closely Human Leukocyte Antigen (HLA)-Matched Adenovirus-specific T Lymphocytes (Viralym-A)	No drug interventions	treatment	1	withdrawn
NCT02851576	Clinical Grade Adenovirus Specific T Cells for Immunotherapy After Allogeneic Stem Cell Transplantation (CTL-ADV)	No drug interventions	treatment	1 / 2	completed
NCT00880789	Safety, Toxicity and MTD of One Intravenous IV Injection of Donor CTLs Specific for CMV and Adenovirus	No drug interventions	treatment	1	completed
NCT05305040	Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant	Posoleucel	prevention	2 / 3	terminated
NCT03475212	Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation	Virus Specific T-Cell	treatment	1 / 2	active_not_recruiting
NCT03159364	Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections	No drug interventions	treatment	1 / 2	unknown_status
NCT04693637	Posoleucel (ALVR105, Formerly Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant	Posoleucel	prevention	2 / 3	completed
NCT02087306	Study to Assess the Safety and Efficacy of Brincidofovir in Treatment of Early Versus Late Adenovirus Infection	Brincidofovir	treatment	3	completed
NCT00711035	Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL)	No drug interventions	treatment	1 / 2	completed
NCT02702427	Virus-specific ImmunoTherapy Following Allogeneic Stem Cell Transplantation	No drug interventions	treatment	1 / 2	withdrawn
NCT04722029	Pilot Study of Haploidentical Donor Adenovirus Specific T-lymphocytes to Treat Refractory Adenovirus Infections	No drug interventions	treatment	1 / 2	recruiting
NCT01325636	Injection of CD4 and CD8 + T Cells Anti-Cytomegalovirus (CMV) or Anti-adenovirus	No drug interventions	treatment	1 / 2	completed
NCT04706923	A Phase 2a Study of IV BCV in Subjects With Adenovirus Infection	No drug interventions	treatment	2	recruiting
NCT01923766	Cytotoxic T Cells to Prevent Virus Infections	No drug interventions	treatment	1	completed